PEGA
Price
$31.39Alerts
Change
-$0.14 (-0.44%)
Updated
Nov 11 closing price
Capitalization
5.33B
98 days until earnings call
Intraday BUY SELL Signals
ZCMD
Price
$0.98Alerts
Change
+$0.02 (+2.08%)
Updated
Nov 11 closing price
Capitalization
8.65M
Intraday BUY SELL Signals
Interact to see
Advertisement

PEGA vs ZCMD

PEGA vs ZCMD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PEGA vs. ZCMD commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEGA is a Hold and ZCMD is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PEGA with price predictions
Nov 10, 2026

Momentum Indicator for PEGA turns negative, indicating new downward trend

PEGA saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 68 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for PEGA turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 37 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.

PEGA moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PEGA crossed bearishly below the 50-day moving average on November 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEGA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PEGA's RSI Indicator exited the oversold zone, 28 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where PEGA advanced for three days, in 215 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

PEGA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 139 of 200 cases where PEGA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 19 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. PEGA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.505) is normal, around the industry mean (-1.906). P/E Ratio (16.963) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (2.989) is also within normal values, averaging (2.824). Dividend Yield (0.004) settles around the average of (0.069) among similar stocks. P/S Ratio (3.814) is also within normal values, averaging (70.383).

The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PEGA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ZCMD with price predictions
Nov 10, 2026

ZCMD in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 02, 2026

ZCMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 35 of 42 cases where ZCMD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ZCMD's RSI Indicator exited the oversold zone, 29 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 50 cases where ZCMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

Following a +4.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZCMD advanced for three days, in 128 of 173 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZCMD as a result. In 110 of 115 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

ZCMD moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZCMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for ZCMD entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.464) is normal, around the industry mean (4.477). P/E Ratio (-0.017) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (0.800) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.002) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. ZCMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZCMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

FUNDAMENTALS RATINGS
PEGA vs ZCMD: Fundamental Ratings
PEGA
ZCMD
OUTLOOK RATING
1..100
7281
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1997
PRICE GROWTH RATING
1..100
7295
P/E GROWTH RATING
1..100
927
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZCMD's Valuation (55) in the null industry is in the same range as PEGA (81) in the Information Technology Services industry. This means that ZCMD’s stock grew similarly to PEGA’s over the last 12 months.

ZCMD's Profit vs Risk Rating (100) in the null industry is in the same range as PEGA (100) in the Information Technology Services industry. This means that ZCMD’s stock grew similarly to PEGA’s over the last 12 months.

PEGA's SMR Rating (19) in the Information Technology Services industry is significantly better than the same rating for ZCMD (97) in the null industry. This means that PEGA’s stock grew significantly faster than ZCMD’s over the last 12 months.

PEGA's Price Growth Rating (72) in the Information Technology Services industry is in the same range as ZCMD (95) in the null industry. This means that PEGA’s stock grew similarly to ZCMD’s over the last 12 months.

ZCMD's P/E Growth Rating (7) in the null industry is significantly better than the same rating for PEGA (92) in the Information Technology Services industry. This means that ZCMD’s stock grew significantly faster than PEGA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PEGAZCMD
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 23 days ago
68%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (PEGA: $31.53 vs. ZCMD: $0.96)
Brand notoriety: PEGA and ZCMD are both not notable
PEGA represents the Packaged Software, while ZCMD is part of the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: PEGA: 90% vs. ZCMD: 32%
Market capitalization -- PEGA: $5.33B vs. ZCMD: $8.65M
PEGA [@Packaged Software] is valued at $5.33B. ZCMD’s [@Services to the Health Industry] market capitalization is $8.65M. The market cap for tickers in the [@Packaged Software] industry ranges from $39 to $269.45B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $49.18B. The average market capitalization across the [@Packaged Software] industry is $10.32B. The average market capitalization across the [@Services to the Health Industry] industry is $3.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PEGA’s FA Score shows that 1 FA rating(s) are green while ZCMD’s FA Score has 1 green FA rating(s).

  • PEGA’s FA Score: 1 green, 4 red.
  • ZCMD’s FA Score: 1 green, 4 red.
According to our system of comparison, ZCMD is a better buy in the long-term than PEGA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PEGA’s TA Score shows that 5 TA indicator(s) are bullish while ZCMD’s TA Score has 4 bullish TA indicator(s).

  • PEGA’s TA Score: 5 bullish, 5 bearish.
  • ZCMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both PEGA and ZCMD are a good buy in the short-term.

Price Growth

PEGA (@Packaged Software) experienced а -8.21% price change this week, while ZCMD (@Services to the Health Industry) price change was -3.01% for the same time period.

The average weekly price growth across all stocks in the @Packaged Software industry was -2.44%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was +4.03%.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +0.67%. For the same industry, the average monthly price growth was +2.59%, and the average quarterly price growth was +28.54%.

Reported Earning Dates

PEGA is expected to report earnings on Feb 17, 2027.

Industries' Descriptions

@Packaged Software (-2.44% weekly)

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

@Services to the Health Industry (+0.67% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
Interact to see
Advertisement

PEGA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEGA has been closely correlated with FRSH. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if PEGA jumps, then FRSH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEGA
1D Price
Change %
PEGA100%
+1.28%
FRSH - PEGA
68%
Closely correlated
-1.08%
SAP - PEGA
67%
Closely correlated
-1.55%
DOCU - PEGA
66%
Closely correlated
-0.12%
VERX - PEGA
66%
Closely correlated
+3.12%
WDAY - PEGA
64%
Loosely correlated
-0.69%
More

ZCMD and

Correlation & Price change

A.I.dvisor tells us that ZCMD and ZETA have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZCMD and ZETA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZCMD
1D Price
Change %
ZCMD100%
-3.81%
ZETA - ZCMD
22%
Poorly correlated
+8.17%
SOHU - ZCMD
21%
Poorly correlated
-2.61%
PEGA - ZCMD
21%
Poorly correlated
+1.28%
XBP - ZCMD
21%
Poorly correlated
-6.38%
CHKP - ZCMD
20%
Poorly correlated
+0.42%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STZ145.51N/A
N/A
Constellation Brands
CARS13.37-0.11
-0.82%
Cars.com
ASTC4.27-0.05
-1.16%
Astrotech Corp
HAYW16.61-0.28
-1.66%
Hayward Holdings
KRMD3.16-0.07
-2.17%
KORU Medical Systems